Table 1 The effect of the different ratio of drug to lipid on the SLN characteristic
Formulation name | RES (mg) | Average size (nm) | PDI | ZP (mV) | EE (%) |
---|---|---|---|---|---|
SLN | 0 | 219.7 | 0.480 | − 16.1 | – |
SLN-RES-30 | 30 | 257.6 | 0.447 | − 17.7 | 64.3 |
SLN-RES-50 | 50 | 248.3 | 0.422 | − 16.5 | 79.7 |
SLN-RES-70 | 70 | 224.3 | 0.474 | − 17.3 | 60.1 |